New York, August 02, 2016 -- Moody's Investors Service, ("Moody's") downgraded the senior unsecured ratings of Teva Pharmaceutical Industries Ltd ("Teva") and select subsidiaries to Baa2 from Baa1. The ratings on debt at several other Teva subsidiaries, which were assigned on July 18 are unchanged at Baa2. This concludes the review for downgrade initiated on July 27, 2015. The outlook is stable.
Vollständigen Artikel bei Moodys lesen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.